Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02704481 · ClinicalTrials.gov registry record · Phase 4
Non-surgical Alternatives to Treatment of Failed Medical Abortion
A Phase 4 study, sponsored by Gynuity Health Projects.
- Terminated
- Registry status
- Phase 4
- Development phase
- 16
- Enrollment target
NCT02704481 is a Phase 4 study that was terminated before completion, run by Gynuity Health Projects. The registered enrollment target is 16 participants.
The verdict
NCT02704481, a Phase 4 study, was terminated before completion, sponsored by Gynuity Health Projects.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 16 participants
- Enrollment target
Study Summary
The primary outcome of this study is to compare the effectiveness of a second complete course of 200 mg mifepristone and 800 mcg misoprostol for ongoing pregnancy following mifepristone-misoprostol medical abortion.
Interventions
- DRUG Mifepristone
- DRUG Misoprostol
- DRUG Placebo mifepristone
- DRUG Placebo misoprostol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2016-06-01 |
| Est. Completion | 2019-01-16 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02704481
The ClinicalTrials.gov registry entry for NCT02704481 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gynuity Health Projects, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Mifepristone is the first listed.
NCT02704481 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02704481 about?
NCT02704481 is a clinical study titled "Non-surgical Alternatives to Treatment of Failed Medical Abortion". The primary outcome of this study is to compare the effectiveness of a second complete course of 200 mg mifepristone and 800 mcg misoprostol for ongoing pregnancy following mifepristone-misoprostol medical abortion.
What is the current status of trial NCT02704481?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 16 participants. The study started on 2016-06-01. Estimated completion is 2019-01-16.
What interventions are being tested in trial NCT02704481?
The interventions under investigation include: Mifepristone (DRUG), Misoprostol (DRUG), Placebo mifepristone (DRUG), Placebo misoprostol (DRUG).
Who is sponsoring clinical trial NCT02704481?
This trial is sponsored by Gynuity Health Projects, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.